METABOLIC SYNDROME AND COGNITIVE DISORDERS
Keywords:
Metabolic syndrome, cognitive impairment, insulin resistance, inflammation, neurodegeneration, oxidative stress, Alzheimer's disease.Abstract
Metabolic syndrome (MetS), a cluster of diseases that includes central obesity, hypertension, hyperglycemia, and dyslipidemia, has emerged as a significant public health problem. In addition to its association with cardiovascular disease and diabetes, MetS is increasingly associated with cognitive impairment and neurodegenerative diseases such as Alzheimer's disease. The underlying mechanisms linking MetS to cognitive decline include chronic inflammation, insulin resistance, oxidative stress, and vascular dysfunction, which impair brain health and neuronal function. This article explores the complex relationship between MetS and cognitive impairment, highlights the physiological and biochemical pathways, and discusses preventive and therapeutic strategies to mitigate the impact of MetS on cognitive health. Recognizing the interrelationship between metabolic health and cognitive function is critical for developing integrated approaches to address the dual burden of physical and neurological diseases.
References
1. Alberti, K. G., Zimmet, P., & Shaw, J. (2005). The metabolic syndrome—a new worldwide definition. The Lancet, 366(9491), 1059-1062.
2. Biessels, G. J., & Reagan, L. P. (2015). Hippocampal insulin resistance and cognitive dysfunction. Nature Reviews Neuroscience, 16(11), 660-671.
3. Grundy, S. M. (2008). Metabolic syndrome: A multiplex cardiovascular risk factor. The Journal of Clinical Endocrinology & Metabolism, 93(11_supplement_1), S14-S21.
4. Petersen, R. C. (2004). Mild cognitive impairment as a diagnostic entity. Journal of Internal Medicine, 256(3), 183-194.
5. Arnold, S. E., et al. (2018). Brain insulin resistance in type 2 diabetes and Alzheimer disease: Concepts and conundrums. Nature Reviews Neurology, 14(3), 168-181.
6. Wellen, K. E., & Hotamisligil, G. S. (2005). Inflammation, stress, and diabetes. The Journal of Clinical Investigation, 115(5), 1111-1119.
7. Rains, J. L., & Jain, S. K. (2011). Oxidative stress, insulin signaling, and diabetes. Free Radical Biology and Medicine, 50(5), 567-575.
8. Gorelick, P. B., et al. (2011). Vascular contributions to cognitive impairment and dementia. Stroke, 42(9), 2672-2713.
9. Teunissen, C. E., et al. (2015). Adiponectin in the brain: Relationships with metabolic and cognitive factors. Frontiers in Neuroscience, 9, 17.
10. Eckel, R. H., et al. (2005). The metabolic syndrome. The Lancet, 365(9468), 1415-1428.
11. Gustafson, D. R., et al. (2004). Adiposity indicators and dementia over 32 years in Sweden. Neurology, 63(10), 1971-1976.
12. Kivipelto, M., et al. (2005). Obesity and vascular risk factors at midlife and the risk of dementia and Alzheimer disease. Archives of Neurology, 62(10), 1556-1560.
Published
Issue
Section
License
Copyright (c) 2024 Shohista Bobojonova, Muyassar Turdiyeva, Shaxnoza Xudayberganova, Odila Majidova, Xilola Usmonova
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
All Rights Reserved.
